Comprehensive Landscape of ARID Family Members and Their Association with Prognosis and Tumor Microenvironment in Hepatocellular Carcinoma

Figure 4

Prognostic values of ARID members in progression-free survival of all HCC patients. Survival assays related that (a) JARID2, ARID5B, and ARID5A; (b) ARID1B, ARID2, and JARID3A; and (c) JARID3B and ARID1A predicted a shorter overall survival in HCC patients. (d) Patients with high ARID3C expression exhibited a longer overall survival.

(a)

(b)

(c)

(d)